Chemoinformaics analysis of Dehydro-isoeugenol
| Molecular Weight | 162.188 | nRot | 2 |
| Heavy Atom Molecular Weight | 152.108 | nRig | 8 |
| Exact Molecular Weight | 162.068 | nRing | 1 |
| Solubility: LogS | -2.813 | nHRing | 0 |
| Solubility: LogP | 2.738 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 24.9719 |
| nHD | 1 | BPOL | 11.7681 |
| QED | 0.453 |
| Synth | 4.607 |
| Natural Product Likeliness | 1.503 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.424 |
| Pgp-sub | 0.055 |
| HIA | 0.02 |
| CACO-2 | -4.287 |
| MDCK | 0.0000259 |
| BBB | 0.127 |
| PPB | 0.920888 |
| VDSS | 2.474 |
| FU | 0.0205099 |
| CYP1A2-inh | 0.964 |
| CYP1A2-sub | 0.93 |
| CYP2c19-inh | 0.94 |
| CYP2c19-sub | 0.822 |
| CYP2c9-inh | 0.828 |
| CYP2c9-sub | 0.517 |
| CYP2d6-inh | 0.162 |
| CYP2d6-sub | 0.554 |
| CYP3a4-inh | 0.428 |
| CYP3a4-sub | 0.265 |
| CL | 5.393 |
| T12 | 0.599 |
| hERG | 0.005 |
| Ames | 0.845 |
| ROA | 0.949 |
| SkinSen | 0.965 |
| Carcinogencity | 0.737 |
| EI | 0.99 |
| Respiratory | 0.979 |
| NR-Aromatase | 0.323 |
| Antiviral | No |
| Prediction | 0.874938 |